Regulatory Compliance

Regulatory Compliance is a comprehensive regulatory automation platform designed for Sponsors, Clinical Sites, and Investigators seeking to accelerate clinical trial submissions and maintain continuous inspection readiness. With clinical sites bearing median regulatory compliance costs of $3,750 per study — frequently exceeding reimbursements of $3,000 — the platform is purpose-built to eliminate paper-based delays, reduce administrative burden, and deliver measurable cost savings across the entire regulatory lifecycle.

Built on the principle of efficiency meeting compliance, the Regulatory Automation suite transforms administrative hurdles into competitive advantages. It harnesses AI-driven tools spanning CMC, pharmacovigilance, submissions, data standards, e-signatures, analytics, and validation to fast-track therapies from lab to market with unmatched compliance confidence and operational speed.

Core Solution Modules

• CMC (Chemistry, Manufacturing, and Controls): Automates data extraction for eCTD Module 3 authoring and annual reports from QMS/LIMS systems, including interactive Process Flow Diagrams, stability trend analysis, full traceability matrices, and FDA validation readiness.
• FDA Searchbot: Performs AI-powered search across FDA deficiency letters, guidance documents, and regulations using natural language queries, real-time result ranking, citation export functionality, and deficiency letter pattern analysis for rapid compliance responses.
• Safety & Pharmacovigilance: Streamlines adverse event reporting, signal detection, and MedDRA coding for global pharmacovigilance compliance, with automated case processing, real-time signal monitoring, cross-jurisdiction mapping, and E2B(R3) export capabilities.
• Narrative Generation: Transforms eCRF data into compliant CIOMS narratives and regulatory reports using AI-driven natural language generation, supporting patient-level narrative creation, standardized medical phrasing, multi-language support, and version control with audit trails.
• DEA Validation: Automates Drug Enforcement Administration license verification and controlled substance compliance checks, offering bulk license validation, expiration date monitoring, real-time status dashboards, and up to 70% cost reduction.
• IRB Submissions: Digitizes Institutional Review Board submissions, amendments, and approvals with workflow automation and e-signatures, including standardized templates, automated routing and reminders, comprehensive audit trails, and real-time approval tracking.
• Document Redaction: Provides AI-powered identification and removal of PII, PHI, and sensitive data across regulatory documents, with HIPAA/GDPR/EMA compliance, context-aware redaction, bulk processing capabilities, and pre- and post-redaction validation.
• Submission Operations & Labelling: Offers a unified platform for Lot Distribution Reports, SPL generation, label validation, and eCTD pre-flight checks, with FDA/EMA gateway validation, automated XML formatting, artifact hierarchy verification, and multi-region submission support.
• eSignature: Enables secure, legally binding e-signatures to streamline document approvals, featuring secure authentication, automated notification flows, and audit-ready time stamping to ensure regulatory compliance.
• SDTM Analytics: Bridges clinical data and global regulatory standards with an automated mapping engine, supporting automated CDISC SDTM mapping, real-time data validation, cross-study standardization, and instant analytic dashboards for safety and efficacy insights.

Key Benefits

• Guaranteed Inspection Readiness: Maintains immutable audit trails and compliant e-signatures across all workflows to minimize regulatory findings and avoid costly trial disruptions, while centralizing CMC, pharmacovigilance, and submission documents for instant, verifiable inspection readiness at any time.
• Accelerated Submission Velocity: Automates eCTD Module 3 authoring, narrative generation, and pre-flight validations to eliminate manual errors and speed FDA/EMA filings, while freeing high-value personnel — including Site Coordinators, CRAs, and Regulatory Affairs Staff — from repetitive tasks such as DEA checks and document redaction.
• End-to-End Traceable Control: Implements Secure Document Exchange (DocXchange) to share sensitive trial data with internal teams and external partners including CROs and Sites, with full security, traceability, and controlled access. AI-driven classification, redaction, and validation ensure every document meets HIPAA/GDPR/EMA standards from upload.
• Financial Optimization: Cuts expenses by up to 70% on validations and manual processing, avoiding remediation fees and storage overheads, while compressing submission timelines by weeks to accelerate therapies to market and maximize R&D investment returns.
• Strategic Intelligence & Precision: Guarantees regulator-ready formats for SPL, LDR, and CIOMS reports to eliminate rejection risks, and provides standardized, real-time visualizations of trial health for earlier identification of safety signals and faster strategic decision-making.

Industry Context & Performance Benchmarks

• Organizations using unified data platforms with integrated eTMF/eISF solutions report 45% faster site activation compared to manual processes.
• The average cost of non-compliance is 2.71 times more costly than implementing compliance measures.
• The regulatory oversight market, driven by compliance automation, is projected to reach $32.2 billion by 2029, reflecting a CAGR of 8.7%.
• Implementing a validated eSignature system can lead to completing 70% of eSignatures within 24 hours.

The platform supports multi-region regulatory submissions and integrates with existing QMS and LIMS systems, making it suitable for global clinical operations requiring consistent compliance across FDA, EMA, and other regulatory frameworks.